University of California San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT01237353
In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
Looking for future studies?
Notify Me18 year–59 year
All sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
Investigators will evaluate the extent and time course of gastric re-acidification after oral betaine HCl in healthy volunteers with pharmacologically-induced hypochlorhydria. After betaine HCl dose, gastric pH will be continuously monitored for 2 hours.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
betaine hydrochloride 1500mg po x 1 on day 5
rabeprazole po daily x 5 days
Time frame: 30 minutes
Gastric pH levels monitored with a Heidelberg pH capsule (HC) which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis. When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours.
Time frame: 2 hours after dose of betaine HCl
When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours
University of California, San Francisco
Other
Pilot Study Evaluating Gastric Re-acidification Using Betaine Hydrochloride in Healthy Volunteers With Pharmacologically Induced Hypochlorhydria
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06649409
Pharmacodynamic
Neu-Ulm, Germany
View Trial DetailsNCT04828005
Pharmacodynamic
Salt Lake City, Utah, United States
View Trial DetailsNCT03344627
Carbapenem, Clinical Outcome
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT03011996
Drug Interaction, Pharmacodynamic
Busan, South Korea
View Trial Details